echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Dream, platform, thank you

    Dream, platform, thank you

    • Last Update: 2018-02-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: last night on February 3, 2018, the annual dinner of Wuxi apptec's ecosystem was held in the Himalaya Hotel, zhuomea, Shanghai Compared with the cold outdoor temperature, the indoor is a warm spring More than 400 industry elites from China's pharmaceutical research and development, investment and financing, medical diagnosis and other fields gathered together They have the joy of new and old friends, the friendship of sharing weal and woe, the celebration of the fruitful results of 2017, and the infinite imagination of 2018 "Thank you in particular for the trust, support, urging and competition you have shown us in the past 17 years Without you, there would be no Wuxi apptec today." ——The theme of this dinner is "a dream, a platform, thank you" Dr Li Ge, chairman of Wuxi apptec group, warmly welcomed you and led the management of Wuxi apptec to celebrate the new year Dr Li Ge joked about last week's impromptu "don't ask the West and the East" at the annual conference of Wuxi apptec, which was asked by many industry partners how long they had prepared "This poem is improvised, but we have prepared for 17 years Along the way, we have suffered, we have laughed, and finally we have come to such a great era Thank you in particular for the trust, support, urging and competition we have received in the past 17 years Without you, there would be no today's Wuxi apptec! Don't ask the west east, just ask the sincerity! Be honest and dedicated to work and share with others; do the right thing and do it well This is our core values Don't ask the West and East, just ask the dream! Let the world have no medicine or disease This is our dream Don't ask the West and East, just insist! Customer first, integrity, excellence, efficient implementation, cross-border cooperation, change and innovation This is our code of conduct Don't ask Xidong, just ask passion! Passion work, happy life, growth and development in Wuxi apptec This is our culture Don't ask Xidong, just ask courage! Top and bottom desire, the best wins! This is our faith! In 2018, Wuxi apptec will continue to ask the West and the East, just insist, insist on serving everyone well, insist on building a good ecosystem, and we will meet the great era together! " Dr Li Ge and the management of Wuxi apptec group pay homage to the partners of "ecosystem" in the early years! The host of this dinner, Dr Yang Qing, executive vice president, chief strategy officer and chief business officer of Wuxi apptec group, introduced two keynote speakers, Mr Song Ruilin, executive chairman of China pharmaceutical promotion association, and Mr Wang Lei, global executive vice president and President of international business and China of AstraZeneca The two guests agreed that China's medical innovation is entering the best era with broad prospects ▲ Mr Song Ruilin, executive chairman of China pharmaceutical innovation promotion association, delivered a keynote speech - "China's drug regulation in transformation" "2017 has been the most exciting year for pharmaceutical regulatory reform CFDA's accession to ICH in June marks that China's drug review and approval standards are fully in line with the world, greatly facilitating the transition of Chinese drugs from domestic to international, benefiting patients around the world, and realizing the responsibility of a major country In addition, there was a more perfect aggregation mechanism from R & D to capital platform last year It is believed that a more reasonable patent compensation mechanism for new drugs will be introduced in the future, which will transform China's pharmaceutical research and development from high-speed to high-quality " President Song Ruilin stressed that "the ultimate goal of reform is to benefit patients and reduce the social cost of treating diseases We need to focus on innovative drugs, excellent generic drugs, and more high-tech treatments for the benefit of patients around the world, not only for the Chinese people, but also for the people of the world " ▲ Mr Wang Lei, global executive vice president of AstraZeneca, President of international business and China, delivered a keynote speech - "innovation, patient-centered, helping healthy China" Mr Wang Lei, global executive vice president of AstraZeneca, President of international business and China, who had just met with British Prime Minister Theresa May, arrived at the dinner at the first time yesterday afternoon "With the enhancement of China's medical innovation ability, more and more good drugs and therapies will come out in the future One belt, one road, is China's new drug Not only will it focus on the local market, it will also go to the world and make the necessary contribution to the positive implementation of the "one belt and one road initiative" "The so-called innovation should be based on the maximization of patients' interests and create a whole process solution from disease discovery, diagnosis to treatment, which is also the significance of building and upgrading the pharmaceutical industry ecosystem," Wang said In addition, the guests also expressed their own opinions on the current medical innovation pattern Academician Pei gang of Chinese Academy of Sciences commented that "the most important thing for China's biotechnology development to enter a new era is the reform and iteration of management mechanism The reform of CFDA is at the right time and deserves great support and encouragement In 2018, we expect the industry to enter a new era with more vitality and prosperity " "In 2017, CFDA issued a series of policies, including clinical trial management, approval of drugs and medical devices, and technical guidance on research and evaluation of cell therapy products, reflecting the unprecedented determination of the Chinese government to accelerate the research and development of drugs and medical devices, encourage innovation, and promote the development of life Sciences." "China's medical innovation is entering a golden period of development, and we need more close links in the whole industrial chain to form an ecological circle of mutual benefit and common prosperity," said Tony acciarito, President of saimofei Greater China So, which areas are most likely to bring heavy news in 2018? Professor Zhou Wenhao, Dean of pediatrics at Fudan University, focused on innovative therapies "The continuous emergence and iteration of innovative technologies such as gene screening and diagnosis of genetic diseases, gene therapy and stem cell therapy will subvert the traditional medical diagnosis and treatment methods, and better help doctors serve patients with the highest efficiency and lowest cost." Professor Zhou Wenhao said, "we expect these new therapies to cause a storm in the field of universal health In 2018, it is hoped that more and better medical innovation technologies will be born on the platform of Wuxi apptec to benefit Chinese patients " According to Dr Du Ying, founder and CEO of zaiding pharmaceutical, with the implementation of CFDA's new policies one by one, the speed of launching new products will increase unprecedentedly, "2018 will be a year of rapid development for China's medical industry." Pei Gang, academician of the Chinese Academy of Sciences, stressed that "gene editing, car-t and other representatives of new biotechnology have stepped onto the stage, and will continue to expand and deepen this year The close cooperation of biotechnology, big data, artificial intelligence and other interdisciplinary technologies will certainly become the future development trend of medical innovation " For example, the emergence and iteration of genetic technology in the field of genetic disease screening and clinical diagnosis, gene therapy, stem cell therapy and so on will subvert the traditional medical diagnosis and treatment methods, and better help doctors better serve patients with the highest efficiency and lowest cost In 2018, the upward energy of China's pharmaceutical industry is ready to develop, and a multi-faceted innovation ecosystem is forming Let's work together under such a melody and strive for "no hard medicine, no hard disease in the world" In the spring and winter of this year, we will gather here together, and how many exciting breakthroughs can we share! ▲ dinner scene
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.